Michael Gelband’s iShares Biotechnology ETF IBB Stock Holding History

Michael Gelband’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.3M	Buy	+96,038	New	+$16.5M	0.12%	147
2023 Q3	–	Sell	-246,417	Closed	-$31.3M	–	1889
2023 Q2	$31.3M	Buy	+246,417	New	+$32M	0.25%	65
2023 Q1	–	Sell	-72,660	Closed	-$9.54M	–	1920
2022 Q4	$9.54M	Buy	+72,660	New	+$9.39M	0.14%	181
2022 Q2	–	Sell	-100,987	Closed	-$13.2M	–	2151
2022 Q1	$13.2M	Buy	+100,987	New	+$13.2M	0.17%	128
2020 Q4	–	Sell	-100,802	Closed	-$13.7M	–	2133
2020 Q3	$13.7M	Buy	100,802 +71,047	+239%	+$9.64M	0.27%	51
2020 Q2	$4.07M	Buy	29,755 +23,955	+413%	+$3.05M	0.11%	204
2020 Q1	$625K	Buy	+5,800	New	+$668K	0.03%	421
2019 Q4	–	Sell	-79,293	Closed	-$7.89M	–	1691
2019 Q3	$7.89M	Buy	79,293 +50,825	+179%	+$5.32M	0.28%	76
2019 Q2	$3.11M	Buy	+28,468	New	+$3.03M	0.12%	114

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Michael Gelband's IBB Position: Q2 2026 in Review

Michael Gelband opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 96,038 shares worth $18.3M. The stake represents 0.12% of the portfolio and ranks #147 among its holdings. This is a return to the name: Michael Gelband previously reported a position in IBB as recently as Q2 2023.

Michael Gelband first reported a position in IBB in Q2 2019 and has held it in 9 quarters since. The position peaked at $31.3M in Q2 2023. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Michael Gelband held 96,038 shares of iShares Biotechnology ETF worth $18.3M as of Q2 2026.
iShares Biotechnology ETF was a new Michael Gelband position in Q2 2026.
iShares Biotechnology ETF made up 0.12% of Michael Gelband's portfolio in Q2 2026, its #147 holding.
Michael Gelband first reported a position in iShares Biotechnology ETF in Q2 2019 and has held it in 9 quarters since.
Michael Gelband's iShares Biotechnology ETF position peaked at $31.3M in Q2 2023.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.